News Highlights

Check this page for recent news from Appili Therapeutics.

Members of the media can contact us here, or for general inquiries, contact us here.

June 24, 2021
Appili Therapeutics Reports Fiscal Year 2021 Financial and Operational Results Provides Update on Strategy for Fiscal 2022
June 17, 2021
Appili Therapeutics Inc. Expands PRESECO Clinical Trial of Avigan®/Reeqonus™ for Mild-to-Moderate COVID-19 Patients into Mexico and Brazil
May 17, 2021
Independent Data Safety Monitoring Board Recommends Appili Therapeutics Complete Its Phase 3 Avigan®/Reeqonus™ Trial for Mild-to-Moderate COVID-19 Patients
April 19, 2021
Appili Therapeutics to Present at the Bloom Burton & Co. Healthcare Investor Virtual Conference on Wednesday, April 21st, 2021
March 17, 2021
Appili Therapeutics to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference on Friday, March 19th